BIOWIRE2K LA JOLLA, Calif.–Aug. 14, 2006–Stratagene Corporation (Nasdaq:STGN), a developer, manufacturer and marketer of specialized life science research and diagnostics products, announced today that it has entered into a joint development and license agreement with Rosetta Inpharmatics LLC, a wholly-owned subsidiary of Merck & Co., Inc., to create an automated solution for the isolation of […]

Venlo, The Netherlands- QIAGEN NV has entered into a definitive merger agreement with Gentra Systems for $38 million in cash. Gentra, developer, manufacturer and supplier of non-solid phase nucleic acid purification products is focused on the niche market for large-scale blood samples of up to 10 ml. QIAGEN expects the transaction to contribute $6 million […]

Venlo , The Netherlands and Hamburg , Germany – QIAGEN N.V. (NASDAQ: QGEN; Frankfurt , Prime Standard: QIA) and Eppendorf AG today announced that they have formed a strategic alliance that includes co-development and co-marketing of complementary and optimized products. The alliance is intended to link two of the strongest brands and product lines in […]

CHALFONT ST. GILES, UK – GE Healthcare today announced the availability of His MultiTrap™ FF and His MultiTrap HP prepacked 96-well filter plates for convenient screening and rapid, high-throughput parallel purification of histidine-tagged recombinant proteins. The standardized 96-well plate allows great flexibility and consistent well-to-well and plate-to-plate performance to ensure high reproducibility. His MultiTrap 96-well […]